4//SEC Filing
Burgess Julie 4
Accession 0001883722-26-000002
CIK 0001807120other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:11 PM ET
Size
5.7 KB
Accession
0001883722-26-000002
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock option (right to buy)
2026-01-02+150,000→ 150,000 totalExercise: $9.10Exp: 2036-01-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2027, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001883722
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:11 PM ET
- Size
- 5.7 KB